Will an increased dietary folate intake reduce the incidence of cardiovascular disease?

Nutrition Reviews

Volumn 54, Issue 7, 1996, Pages 213-216

  Ubbink, Johan B ^a   Becker, Piet J ^b   Vermaak, W J Hayward ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

CORONARY ARTERY DISEASE; DIETARY INTAKE; HOMOCYSTINURIA; HUMAN; SHORT SURVEY; STATISTICAL CONCEPTS; UNITED STATES;

EID: 0029963687     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.1996.tb03936.x     Document Type: Short Survey

References (20)

1. Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990;21:572-6
2. Genest JJ, McNamara JR, Salem DN, Wilson PWF, Schaefer EJ, Malinow MR. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990;16:1114-9
3. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'leary DH, Wolf PA, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91
4. Arnesen E, Refsum H, Bønaa KH, Ueland PM, Førde OH, Nordrehaug JE. Serum total homocysteine and coronary heart disease. Int J Epidemiol 1995;24: 704-9
5. Robinson K, Mayer EL, Miller DP, Green R, Van Lente F, Gupta A, Kottke-Marchant K, Savon SR, et al. Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease. Circulation 1995;92: 2825-30
6. Kang S, Wong PWK, Norusis M. Homocysteinemia due to folate deficiency. Metabolism 1987;36:458-62
7. Ubbink JB, Vermaak WJH, Van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994;124:1927-33
8. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57
9. Stamler J, Wentworth D, Neator JD for the MRFIT group. Is the relationship between serum cholesterol and to premature death from coronary artery disease continuous and graded? JAMA 1986;256:2823-8
10. Steinberg D. The cholesterol controversy is over. Why did it take so long? Circulation 1989;80:1070-8
11. Ravnskov U. Cholesterol lowering trials in coronary disease: frequency of citation and outcome. Br Med J 1992;305:15-9
12. Strandberg TE, Salomaa VV, Naukkarinen VA, Vanhanen HT, Sarna SJ, Miettinen TA. Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. JAMA 1991;266:1225-9
13. Badford RH, Shear CL, Chremos AN, Dujome C, Franklin FA, Hesney M. Expanded clinical investigation of lovastatin (EXCEL) study results: 1. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolaemia. Arch Intern Med 1991;151:43-9
14. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344: 1383-9
15. Dudman NPB, Hicks C, Wang J, Wilcken DEL. Human arterial endothelial cell detachment in vitro: its promotion by homocysteine and cysteine. Atherosclerosis 1991;91:77-83
16. Tsai J, Perella MA, Yoshizumi M, Hsieh C, Haber E, Schlegel R, Lee M. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci USA 1994;91: 6369-73
17. Heinecke JW, Kawamura M, Suzuki L, Chait A. Oxidation of low density lipoprotein by thiols - superoxide-dependent and superoxide-independent mechanism. J Lipid Res 1993;34:2051-61
18. Rees MM, Rodgers GM. Homocysteinemia - association of a metabolic disorder with vascular disease and thrombosis. Thromb Res 1993;71:337-59
19. Ubbink JB. Homocysteine - an atherogenic and a thrombogenic factor? Nutr Rev 1995;53:323-5
20. Watanabe M, Osada J, Aratani Y, Kluckman K, Reddick R, Malinow MR, Maeda N. Mice deficient in cystathionine beta synthase: animal models for mild and severe homocyst(e)inemia. Proc Natl Acad Sci USA 1995;92:1585-9